BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

572 related articles for article (PubMed ID: 19730112)

  • 1. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Menchise A; Martino R; Scaglione M; Giovine S; Romano L; Balzano A
    J Clin Gastroenterol; 2010 Jul; 44(6):448-51. PubMed ID: 19730112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective evaluation of anticoagulation and transjugular intrahepatic portosystemic shunt for the management of portal vein thrombosis in cirrhosis.
    Senzolo M; M Sartori T; Rossetto V; Burra P; Cillo U; Boccagni P; Gasparini D; Miotto D; Simioni P; Tsochatzis E; A Burroughs K
    Liver Int; 2012 Jul; 32(6):919-27. PubMed ID: 22435854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study.
    De Santis A; Moscatelli R; Catalano C; Iannetti A; Gigliotti F; Cristofari F; Trapani S; Attili AF
    Dig Liver Dis; 2010 Jun; 42(6):451-5. PubMed ID: 19819770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Portal vein thrombosis and liver cirrhosis: Long-term anticoagulation is effective and safe.
    Bergère M; Erard-Poinsot D; Boillot O; Valette PJ; Guillaud O; Chambon-Augoyard C; Dumortier J
    Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):395-402. PubMed ID: 30578107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of antithrombin III concentrates on portal vein thrombosis after splenectomy in patients with liver cirrhosis and hypersplenism.
    Kawanaka H; Akahoshi T; Kinjo N; Konishi K; Yoshida D; Anegawa G; Yamaguchi S; Uehara H; Hashimoto N; Tsutsumi N; Tomikawa M; Maehara Y
    Ann Surg; 2010 Jan; 251(1):76-83. PubMed ID: 19864937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein thrombosis after partial splenic embolization in liver cirrhosis: efficacy of anticoagulation and long-term follow-up.
    Cai M; Zhu K; Huang W; Meng X; He K; Zhou B; Guo Y; Chen J; Shan H
    J Vasc Interv Radiol; 2013 Dec; 24(12):1808-16. PubMed ID: 24099787
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis.
    Delgado MG; Seijo S; Yepes I; Achécar L; Catalina MV; García-Criado A; Abraldes JG; de la Peña J; Bañares R; Albillos A; Bosch J; García-Pagán JC
    Clin Gastroenterol Hepatol; 2012 Jul; 10(7):776-83. PubMed ID: 22289875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
    J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis.
    Pettinari I; Vukotic R; Stefanescu H; Pecorelli A; Morelli M; Grigoras C; Sparchez Z; Andreone P; Piscaglia F;
    Am J Gastroenterol; 2019 Feb; 114(2):258-266. PubMed ID: 30538290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of anticoagulation in non-malignant portal vein thrombosis in patients with liver cirrhosis.
    Artaza T; Lopes M; Romero M; Gómez AZ; de la Cruz G; Sánchez JJ; González C; Gómez R
    Gastroenterol Hepatol; 2018 Dec; 41(10):611-617. PubMed ID: 30049580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Portal vein thrombosis: an unexpected finding in a 28-year-old male with abdominal pain.
    Ferguson JL; Hennion DR
    J Am Board Fam Med; 2008; 21(3):237-43. PubMed ID: 18467536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulation treatment of portal vein thrombosis in a patient with cirrhosis awaiting liver transplantation: A case report.
    Wang J; Chai JS; Zhang YM
    Medicine (Baltimore); 2018 Jun; 97(26):e11183. PubMed ID: 29952969
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis: A Systematic Review and Meta-analysis.
    Loffredo L; Pastori D; Farcomeni A; Violi F
    Gastroenterology; 2017 Aug; 153(2):480-487.e1. PubMed ID: 28479379
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular liver disorders (II): portal vein thrombosis.
    Hoekstra J; Janssen HL
    Neth J Med; 2009 Feb; 67(2):46-53. PubMed ID: 19299846
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergency anticoagulation treatment for cirrhosis patients with portal vein thrombosis and acute variceal bleeding.
    Maruyama H; Takahashi M; Shimada T; Yokosuka O
    Scand J Gastroenterol; 2012 Jun; 47(6):686-91. PubMed ID: 22472055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticoagulation for portal vein thrombosis in cirrhosis.
    Qi X; Han G; Wu K; Fan D
    Am J Med; 2010 Sep; 123(9):e19-20; author reply e21. PubMed ID: 20800136
    [No Abstract]   [Full Text] [Related]  

  • 18. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of six-month outcome of patients initially treated for acute deep vein thrombosis with a low molecular weight heparin Certoparin at a fixed, body-weight-independent dosage or unfractionated heparin.
    Harenberg J; Riess H; Büller HR; Brom J; Weidinger G; Huisman MV
    Haematologica; 2003 Oct; 88(10):1157-62. PubMed ID: 14555312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-molecular-weight heparin treatment for portal vein thrombosis in liver cirrhosis: Efficacy and the risk of hemorrhagic complications.
    Kwon J; Koh Y; Yu SJ; Yoon JH
    Thromb Res; 2018 Mar; 163():71-76. PubMed ID: 29407630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.